4月17日,记者了解到,阿里巴巴AI模型DAMO PANDA被FDA(美国食品和药物管理局)认定为“突破性医疗器械”。 大模型时代,AI医疗的应用场景正在不断被拓宽。FDA从2016年起设立“突破性医疗器械认定”,旨在应对威胁人类健康的重大疾病,鼓励创新医疗技术发展。公开资料中,这是大模型首次被FDA认定为“突破性医疗器械”。 胰腺癌有着“癌症之王”之称、早期诊断率极低,DAMO PANDA是...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.